Skip to Content

Onco, Volume 3, Issue 3

2023 September - 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Review
  • Open Access
1 Citations
6,335 Views
16 Pages

22 August 2023

Non-small-cell lung cancer (NSCLC) is a heterogeneous group of diseases accounting for 80–85% of lung cancers. A molecular subset of NSCLC (1–2.5%) harboring molecular rearrangements of the tyrosine kinase gene ROS1 is defined as ROS1-pos...

  • Article
  • Open Access
2 Citations
2,583 Views
14 Pages

Machine Learning-Based Model Helps to Decide which Patients May Benefit from Pancreatoduodenectomy

  • Emanuel Vigia,
  • Luís Ramalhete,
  • Edite Filipe,
  • Luís Bicho,
  • Ana Nobre,
  • Paulo Mira,
  • Maria Macedo,
  • Catarina Aguiar,
  • Sofia Corado and
  • Hugo P. Marques
  • + 4 authors

10 August 2023

Pancreatic ductal adenocarcinoma is an invasive tumor with similar incidence and mortality rates. Pancreaticoduodenectomy has morbidity and mortality rates of up to 60% and 5%, respectively. The purpose of our study was to assess preoperative feature...

  • Article
  • Open Access
1 Citations
3,565 Views
10 Pages

Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients

  • Constantin N. Baxevanis,
  • Savvas Stokidis,
  • Maria Goulielmaki,
  • Angelos D. Gritzapis and
  • Sotirios P. Fortis

26 July 2023

Background: Various studies have reported associations between frequencies of total peripheral blood lymphocytes and prostate cancer prognosis, but none so far has addressed the prognostic role of CD8+ T-lymphocyte subsets. Methods: A total of 43 pro...

  • Review
  • Open Access
11 Citations
14,726 Views
18 Pages

18 July 2023

NUP98 fusions constitute a small subgroup of AML patients and remain a high-risk AML subtype. There are approximately 30 types of NUP98 fusions identified in AML patients. These patients show resistance to currently available therapies and poor clini...

  • Review
  • Open Access
6 Citations
7,538 Views
20 Pages

15 July 2023

Esophageal cancer is a formidable challenge in the realm of cancer treatment. Conventional methods such as surgery, chemotherapy, and immunotherapy have demonstrated limited success rates in managing this disease. In response, targeted drug therapies...

XFacebookLinkedIn
Onco - ISSN 2673-7523